MedTrace Logo

Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting

NCT02830906 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2016-07-13

No results posted yet for this study

Summary

We would like to know the prophylactic anti-emetic effect of ramosetron compare to ondansetron in patient undergone total knee arthroplasty with spinal anesthesia and intrathecal morphine .

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

ramosetron

intravenous ramosetron 0.3 mg before spinal anesthesia and intrathecal morphine

DRUG

Ondansetron

intravenous ondansetron 8 mg before spinal anesthesia and intrathecal morphine

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • piya pinsornsak, md · Thammasat University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-02-28
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830906 on ClinicalTrials.gov